1. Home
  2. RLYB vs CMBM Comparison

RLYB vs CMBM Comparison

Compare RLYB & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • CMBM
  • Stock Information
  • Founded
  • RLYB 2018
  • CMBM 2011
  • Country
  • RLYB United States
  • CMBM United States
  • Employees
  • RLYB N/A
  • CMBM N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • RLYB Health Care
  • CMBM Technology
  • Exchange
  • RLYB Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • RLYB 45.2M
  • CMBM 26.5M
  • IPO Year
  • RLYB 2021
  • CMBM 2019
  • Fundamental
  • Price
  • RLYB $0.90
  • CMBM $0.81
  • Analyst Decision
  • RLYB Buy
  • CMBM Strong Buy
  • Analyst Count
  • RLYB 6
  • CMBM 3
  • Target Price
  • RLYB $8.10
  • CMBM $5.50
  • AVG Volume (30 Days)
  • RLYB 126.0K
  • CMBM 282.9K
  • Earning Date
  • RLYB 11-07-2024
  • CMBM 02-13-2025
  • Dividend Yield
  • RLYB N/A
  • CMBM N/A
  • EPS Growth
  • RLYB N/A
  • CMBM N/A
  • EPS
  • RLYB N/A
  • CMBM N/A
  • Revenue
  • RLYB $598,000.00
  • CMBM $172,215,000.00
  • Revenue This Year
  • RLYB N/A
  • CMBM N/A
  • Revenue Next Year
  • RLYB N/A
  • CMBM $16.49
  • P/E Ratio
  • RLYB N/A
  • CMBM N/A
  • Revenue Growth
  • RLYB N/A
  • CMBM N/A
  • 52 Week Low
  • RLYB $0.84
  • CMBM $0.66
  • 52 Week High
  • RLYB $3.46
  • CMBM $6.45
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 38.42
  • CMBM 45.50
  • Support Level
  • RLYB $0.84
  • CMBM $0.68
  • Resistance Level
  • RLYB $0.94
  • CMBM $0.95
  • Average True Range (ATR)
  • RLYB 0.07
  • CMBM 0.10
  • MACD
  • RLYB -0.02
  • CMBM 0.02
  • Stochastic Oscillator
  • RLYB 17.79
  • CMBM 50.68

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: